207_Combined course Presentations

First page Table of contents Previous page 212 Next page Last page

Endpoints

• Primary: Safety

• Secondary:

Humoral immunogenicity Cell-mediated immunogenicity Impact of escalating doses of HER2

G. Curigliano et al. 2016

Made with